Expand REVB Menu
REVB MENU

REVB Stock Posts


REVB #RevelationBiosciences stock declines -18.4% in premarket,

Premarket Decliner

REVB Revelation Biosciences2.82-0.05-1.7%

Premarket:2.30-0.52 (-18.4%)

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

ACCESS NewswireTue, 9-Sep 8:13 AM
REVB #RevelationBiosciences stock declines -21.2% in premarket,

Premarket Decliner

REVB Revelation Biosciences3.40+0.13+4.0%

Premarket:2.68-0.72 (-21.2%)

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Business WireMon, 17-Mar 6:00 AM
REVB #RevelationBiosciences stock declines -33.5% in premarket,

Premarket Decliner

REVB Revelation Biosciences2.09+1.05+101.4%

Premarket:1.39-0.70 (-33.5%)

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Business WireWed, 21-Aug 5:30 PM
REVB #RevelationBiosciences stock declines -61.5% in premarket,

Premarket Decliner

REVB Revelation Biosciences8.80+0.85+10.7%

Premarket:3.39-5.41 (-61.5%)

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Business WireThu, 1-Feb 6:00 AM
Load Earlier Posts
Market Data Delayed 15 Minutes